Company intelligence / Profile preview

Attune Neurosciences

San Francisco, California, United Statesattuneneuro.com ↗

Ownership: Private
Employees: ~14
Development stage: Other

Overview

Attune Neurosciences has developed a wearable device using low-intensity focused ultrasound to non-invasively modulate deep brain activity. Early clinical trials are underway targeting sleep/wake disorders and other neuropsychiatric conditions. No published pivotal results yet; focus remains on demonstrating safety and proof-of-mechanism.

Therapeutic areas: PsychiatryNeurology
Modalities: Device (Wearable)Non-pharmacological therapy (Neurostimulation via low-intensity focused ultrasound)
Industry: Therapeutic Medical Devices

Partnerships

National Institutes of HealthU.S. Special Operations CommandU.S. Air ForceDefense Advanced Research Projects Agency [DARPA]venture capital partners

Beyond the preview

Go deeper on Attune Neurosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Attune Neurosciences.

Explore the full profile